Disclosure Of Fair Value Measurement [Text Block]

Hyloris Pharmaceuticals SA - Filing #5880974

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
4
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
41,335,000 EUR
47,681,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
9,192,000 EUR
8,613,000 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
86,471,000 EUR
121,513,000 EUR
140,000 EUR
476,000 EUR
945,000 EUR
32,143,000 EUR
4,460,000 EUR
39,069,000 EUR
80,761,000 EUR
476,000 EUR
121,513,000 EUR
140,000 EUR
2,162,000 EUR
4,460,000 EUR
53,909,000 EUR
476,000 EUR
121,513,000 EUR
1,622,000 EUR
65,381,000 EUR
140,000 EUR
4,460,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.